Zdrowie i gospodarka · 30/06/2021
FDA Requests Public Comment on Proposed Collection of Information for MedWatch Adverse Experience Reporting Program
The Food and Drug Administration is seeking public input on its proposed collection of information for the MedWatch program, which tracks adverse experiences with medical products, as required by the Paperwork Reduction Act of 1995.
Source: Federal Register — Food and Drug AdministrationOpen original release →